These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6745 related items for PubMed ID: 2572100

  • 1. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S, Wakamatsu K, Inoue S, Fujita K.
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [Abstract] [Full Text] [Related]

  • 2. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K, Ito S, Fujita K.
    Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
    [Abstract] [Full Text] [Related]

  • 3. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S, Jimbow K, Kato T, Kiyota M, Fujita K.
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [Abstract] [Full Text] [Related]

  • 4. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K, Walsh N, Hara H, Jimbow K, Chen H, Ito S.
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [Abstract] [Full Text] [Related]

  • 5. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
    Wakamatsu K, Ito S, Fujita K.
    Acta Derm Venereol; 1990 Apr; 70(5):367-72. PubMed ID: 1980967
    [Abstract] [Full Text] [Related]

  • 6. Some indolic compounds as markers of the melanocyte activity.
    Hansson C.
    Acta Derm Venereol Suppl (Stockh); 1988 Apr; 138():1-60. PubMed ID: 3176811
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of melanocytic metabolites in fertile women.
    Carstam R, Hansson C, Rorsman H, Rosengren E, Sjöberg NO, Wirestrand LE.
    Acta Derm Venereol; 1985 Apr; 65(6):543-5. PubMed ID: 2420122
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
    Saito N, Morishima T.
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
    [Abstract] [Full Text] [Related]

  • 10. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K, Miyake Y, Homma K, Yasuda K, Izumi Y, Tsutsumi A, Ito S.
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [Abstract] [Full Text] [Related]

  • 11. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
    Hansson C, Wirestrand LE, Aronsson A, Rorsman H, Rosengren E.
    Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
    [Abstract] [Full Text] [Related]

  • 12. Insect cuticular melanins are distinctly different from those of mammalian epidermal melanins.
    Barek H, Sugumaran M, Ito S, Wakamatsu K.
    Pigment Cell Melanoma Res; 2018 May; 31(3):384-392. PubMed ID: 29160957
    [Abstract] [Full Text] [Related]

  • 13. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C, Fiedler H, Wohlrab W, Wozniak KD.
    Dermatol Monatsschr; 1986 May; 172(9):541-4. PubMed ID: 3098590
    [No Abstract] [Full Text] [Related]

  • 14. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
    Wakamatsu K, Ito S, Horikoshi T.
    Melanoma Res; 1991 May; 1(2):141-7. PubMed ID: 1823626
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G, Agrup P, Andersson T, Falck B, Hansson J-A, Jacobsson S, Rorsman H, Rosengrem A-M, Rosengren E.
    Acta Derm Venereol; 1975 May; 55(5):337-41. PubMed ID: 52967
    [Abstract] [Full Text] [Related]

  • 16. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G, Agrup P, Andersson T, Hafström L, Hansson C, Jacobsson S, Jönsson PE, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1979 May; 59(5):381-8. PubMed ID: 93360
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Melanocyte metabolites in the urine of people of different skin colour.
    Wirestrand LE, Hansson C, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1985 May; 65(4):345-8. PubMed ID: 2413694
    [Abstract] [Full Text] [Related]

  • 19. Urinary free and conjugated 5-S-cysteinyldopa in normal subjects and in patients with melanoma.
    Graef V, Paul E.
    Br J Dermatol; 1982 Jan; 106(1):53-7. PubMed ID: 6800394
    [Abstract] [Full Text] [Related]

  • 20. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
    Pavel S, Muskiet FA.
    Cancer Detect Prev; 1983 Jan; 6(1-2):311-6. PubMed ID: 6883388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 338.